Daniel Ketelhuth new group leader at CMM - News

Asset Publisher

Daniel Ketelhuth new group leader at CMM

The 5th of December, Daniel Ketelhuth was appointed new group leader at CMM. Daniel has been at CMM since 2005 when he started as post doc in Göran Hansson’s (currently Peder Olofsson’s) research group. He is since 2014 Senior Research fellow at KI and focuses his research on understanding immunometabolic mechanisms influencing lipoprotein metabolism and atherosclerosis, and the development of new therapies for cardiovascular diseases.

NEWS

The vital breathing

The vital breathing In a radio interview Eric Herlenius, professor in Pediatrics at Karolinska Institutet, discusses what happens when sudden infant death occurs when a small child stops...

New method of identifying biomarkers for unstable arteriosclerosis

New method of identifying biomarkers for unstable arteriosclerosis Atherosclerosis can develop for decades without causing any discomfort, but when the disease becomes unstable, an acute...

Cell publication gives new understanding of how T and B lymphocytes interact in multiple sclerosis

Cell publication gives new understanding of how T and B lymphocytes interact in multiple sclerosis A study conducted by CMM researcher Faiez al Nimer (shared first author) gives an important...

News Agency Reuters reports about a recent publication by CMM researchers

News Agency Reuters reports about a recent publication by CMM researchers The study suggests that pregnant women with both severe obesity and diabetes may be more likely to have children...

Red blood cells cause cardiovascular injury in type 2 diabetes

Red blood cells cause cardiovascular injury in type 2 diabetes Two new studies, conducted at CMM and KI, indicate that harmful effects of substances secreted from red blood cells could...

Mechanism controlling multiple sclerosis risk identified by CMM researchers

Mechanism controlling multiple sclerosis risk identified by CMM researchers Researchers at CMM have discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that...

CMM researcher Ulf Hedin receives Heart-Lung Foundation’s Great Research Grant 2018

CMM researcher Ulf Hedin receives Heart-Lung Foundation’s Great Research Grant 2018 The great research grant is awarded annually, and is the largest individual grant by the Heart Lung...

CMM researchers have developed a model of neurogenerative disease

CMM researchers have developed a model of neurogenerative disease The research group Applied Immunology and Immunotherapy at CMM has developed a novel model of neurogenerative disease,...

CMM researcher Louise Sjöholm interviewed for the Food Pharmacy podcast

CMM researcher Louise Sjöholm interviewed for the Food Pharmacy podcast Mia Clase and Lina Nertby Aurell are since 2014 running the popular blog Food Pharmacy about the gut flora, good...

Parking space for future research

Parking space for future research CMM in the making, May 1996 The Center for Molecular Medicine (CMM) arose from an idea of gathering interdisciplinary research competence and...